M Bernhard1, N H Behrens2, J Wnent3, S Seewald3, S Brenner4, T Jantzen3, A Bohn5, J T Gräsner3, M Fischer2. 1. Emergency Department, University of Leipzig, Liebigstraße 20, 04103, Leipzig, Germany. Michael.Bernhard@medizin.uni-leipzig.de. 2. Department of Anaesthesia and Intensive Care, Klinik am Eichert, ALB FILS KLINIKEN GmbH, Postfach 660, 73006, Göppingen, Germany. 3. Institute for Emergency Medicine, University Hospital Schleswig-Holstein, Kiel, Germany. 4. Klinik für Anästhesiologie, Universitätsklinikum Dresden, Dresden, Germany. 5. Emergency Medical Services, City of Muenster, Muenster, Germany.
Abstract
BACKGROUND: Airway management during resuscitation is pivotal for treating hypoxia and inducing reoxygenation. This German Resuscitation Registry (GRR) analysis investigated the influence of the type of airway used in patients treated with manual chest compression (mCC) and automated chest compression devices (ACCD) after out-of-hospital cardiac arrest (OHCA). METHODS: Out of 42,977 patients (1 January 2010-30 June 2016) information on outcome, airway management and method of chest compressions were available for 27,544 patients. Hospital admission under cardiopulmonary resuscitation (CPR), hospital admission with return of spontaneous circulation (ROSC), hospital discharge and discharge with cerebral performance categories 1 and 2 (CPC 1,2) were used to compare outcome in patients treated with mCC vs. ACCD, and classified by endotracheal intubation (ETI), initial supraglottic airway device (SAD) changed into ETI, and only SAD use. RESULTS: Outcomes for hospital admission under ongoing CPR, hospital admission with ROSC, hospital discharge and neurologically intact survival (CPC 1,2) for mCC (84.8%) vs. ACCD (15.2%) groups were: 8.4/38.6%, 39.2/27.2%, 10.6/6.8%, 7.9/4.7% (p < 0.001), respectively. Only mCC with SAD/ETI for ever ROSC (OR 1.466, 95% CI: 1.353-1.588, p < 0.001) and mCC group with SAD/ETI for hospital admission with ROSC showed better outcomes (odds ratio [OR] 1.277, 95% confidence interval [CI]: 1.179-1.384, p < 0.001) in comparison to mCC treated with ETI. Compared to mCC/ETI, all other groups were associated with a decrease in neurologically intact survival. CONCLUSION: Better outcomes were found for mCC in comparison to ACCD and ETI showed better outcomes in comparison to SAD only. This observational registry study raised the hypothesis that SAD only should be avoided or SAD should be changed into ETI, independent of whether mCC or ACCD is used.
BACKGROUND: Airway management during resuscitation is pivotal for treating hypoxia and inducing reoxygenation. This German Resuscitation Registry (GRR) analysis investigated the influence of the type of airway used in patients treated with manual chest compression (mCC) and automated chest compression devices (ACCD) after out-of-hospital cardiac arrest (OHCA). METHODS: Out of 42,977 patients (1 January 2010-30 June 2016) information on outcome, airway management and method of chest compressions were available for 27,544 patients. Hospital admission under cardiopulmonary resuscitation (CPR), hospital admission with return of spontaneous circulation (ROSC), hospital discharge and discharge with cerebral performance categories 1 and 2 (CPC 1,2) were used to compare outcome in patients treated with mCC vs. ACCD, and classified by endotracheal intubation (ETI), initial supraglottic airway device (SAD) changed into ETI, and only SAD use. RESULTS: Outcomes for hospital admission under ongoing CPR, hospital admission with ROSC, hospital discharge and neurologically intact survival (CPC 1,2) for mCC (84.8%) vs. ACCD (15.2%) groups were: 8.4/38.6%, 39.2/27.2%, 10.6/6.8%, 7.9/4.7% (p < 0.001), respectively. Only mCC with SAD/ETI for ever ROSC (OR 1.466, 95% CI: 1.353-1.588, p < 0.001) and mCC group with SAD/ETI for hospital admission with ROSC showed better outcomes (odds ratio [OR] 1.277, 95% confidence interval [CI]: 1.179-1.384, p < 0.001) in comparison to mCC treated with ETI. Compared to mCC/ETI, all other groups were associated with a decrease in neurologically intact survival. CONCLUSION: Better outcomes were found for mCC in comparison to ACCD and ETI showed better outcomes in comparison to SAD only. This observational registry study raised the hypothesis that SAD only should be avoided or SAD should be changed into ETI, independent of whether mCC or ACCD is used.
Authors: Gavin D Perkins; Ian G Jacobs; Vinay M Nadkarni; Robert A Berg; Farhan Bhanji; Dominique Biarent; Leo L Bossaert; Stephen J Brett; Douglas Chamberlain; Allan R de Caen; Charles D Deakin; Judith C Finn; Jan-Thorsten Gräsner; Mary Fran Hazinski; Taku Iwami; Rudolph W Koster; Swee Han Lim; Matthew Huei-Ming Ma; Bryan F McNally; Peter T Morley; Laurie J Morrison; Koenraad G Monsieurs; William Montgomery; Graham Nichol; Kazuo Okada; Marcus Eng Hock Ong; Andrew H Travers; Jerry P Nolan Journal: Circulation Date: 2014-11-11 Impact factor: 29.690
Authors: Patrick Sulzgruber; Philip Datler; Fritz Sterz; Michael Poppe; Elisabeth Lobmeyr; Markus Keferböck; Sebastian Zeiner; Alexander Nürnberger; Andreas Schober; Pia Hubner; Peter Stratil; Christian Wallmueller; Christoph Weiser; Alexandra-Maria Warenits; Andreas Zajicek; Florian Ettl; Ingrid Magnet; Thomas Uray; Christoph Testori; Raphael van Tulder Journal: Eur Heart J Acute Cardiovasc Care Date: 2017-09-26
Authors: Richard Schalk; Florian H Seeger; Haitham Mutlak; Uwe Schweigkofler; Kai Zacharowski; Norman Peter; Christian Byhahn Journal: Resuscitation Date: 2014-08-07 Impact factor: 5.262
Authors: Gavin D Perkins; Ranjit Lall; Tom Quinn; Charles D Deakin; Matthew W Cooke; Jessica Horton; Sarah E Lamb; Anne-Marie Slowther; Malcolm Woollard; Andy Carson; Mike Smyth; Richard Whitfield; Amanda Williams; Helen Pocock; John J M Black; John Wright; Kyee Han; Simon Gates Journal: Lancet Date: 2014-11-16 Impact factor: 79.321
Authors: M Christ; K I von Auenmüller; T von den Benken; S Fessaras; W Dierschke; H-J Trappe Journal: Med Klin Intensivmed Notfmed Date: 2018-10-23 Impact factor: 0.840
Authors: S Seewald; S Dopfer; J Wnent; B Jakisch; M Heller; R Lefering; J T Gräsner Journal: Scand J Trauma Resusc Emerg Med Date: 2021-02-25 Impact factor: 2.953